Chartwell Pharmaceuticals Email Format
Pharmaceutical ManufacturingNew York, United States51-200 Employees
Chartwell Pharmaceuticals is a US-based pharmaceutical manufacturing company that provides full-service manufacturing, packaging, laboratory, and related supply chain services, with multiple facilities located in Congers, Carmel, and Amityville, New York. The company employs 51 to 200 people and operates cGMP-compliant facilities that have produced prescription pharmaceutical products for more than 25 years. Its capabilities span the product lifecycle, including development, transfer, optimization, and reliable manufacturing, along with formulation work, clinical supplies, and full-scale commercial batches. Through plant expansions, acquisitions, and investments in new dosage forms and technologies, Chartwell has expanded its offerings, including recent expansion into Unit Dose Liquids and a forthcoming Semi-Solids portfolio. Chartwell holds a substantial position in the US generic market, with more than 1,100 Orange Book listings and about 700 commercialized NDCs, and it is recognized as the 5th largest US generic manufacturer by ANDA holdings; all products meet Trade Act Agreement and Buy American Act requirements, with manufacturing conducted in the US for global clients and partners.